Ashton Thomas Securities’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $584K | Buy |
8,467
+70
| +0.8% | +$4.83K | 0.14% | 154 |
|
|
2025
Q1 | $583K | Buy |
8,397
+2,598
| +45% | +$180K | 0.16% | 142 |
|
|
2024
Q4 | $499K | Sell |
5,799
-5,225
| -47% | -$449K | 0.14% | 147 |
|
|
2024
Q3 | $1.31M | Buy |
11,024
+1,899
| +21% | +$226K | 0.26% | 92 |
|
|
2024
Q2 | $1.28M | Buy |
+9,125
| New | +$1.28M | 0.31% | 83 |
|